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Abstract  
 
Objective 
To identify whether preterm surveillance clinics accurately risk-stratify high-risk 
women, by comparing outcomes of those admitted into hospital on the basis of 
asymptomatic testing to those not admitted. 
 
Method  
We performed a subanalysis from a larger prospective cohort study of ultrasonic 
cervical length, quantitative fetal fibronectin (qfFN), and risk of spontaneous preterm 
birth.  We identified 1130 asymptomatic singleton pregnancies at high risk of preterm 
birth, screened between 23 and 28 weeks of gestation at a preterm surveillance clinic 
(PSC) at a tertiary hospital in London, UK.  Gestational age at delivery and proportion 
of preterm births <30 weeks, with neonatal outcomes, were compared between those 
admitted electively when asymptomatic and all others.  
 
Results 
66 (4%) were admitted to hospital from clinic following asymptomatic screening 
(inpatient group).  The mean gestation at delivery for those not electively admitted 
(outpatient group) was term, significantly higher than those admitted from PSC (38.4 
vs 32.1 weeks, p<0.0001).  Preterm births <30 weeks were rare in the outpatient 
group relative to those admitted (1.32% vs 36.4%, p<0.0001). The neonatal mortality 
was 0.188% in the outpatient group compared to 4.55% in those electively admitted 
(p<0.0001).  Other complications such as neonatal deaths, APGAR scores 
SCBU/NICU admissions, respiratory distress syndrome, interventricular haemorrhage 
and low birth weights were significantly lower in patients managed as outpatients.   
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Conclusion 
Preterm surveillance clinic using cervical length and fFN accurately risk triage 
asymptomatic high-risk pregnant women. Women at highest risk of adverse outcome 
can be identified for elective admission to hospital and appropriate management.   
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Introduction  
The clinical burden of preterm birth is substantial. 7.4% of infants are born under 37 
weeks and 57% of neonatal deaths are attributed to preterm birth and its consequences 
[1]. Knowledge of multiple clinical risk factors is insufficient to accurately predict 
preterm labour [2] and allow for prophylactic interventions such antenatal steroids, 
progesterone, cerclage, and in-utero transfer to be efficiently targeted [3-5]. 
Hospitalization is only justified in patients deemed at high risk of imminent delivery 
and poor outcomes.  Despite this a large majority of women admitted to hospital 
deemed at risk of preterm birth do not deliver within 7 days [6] 
 
Cervical length ultrasound surveillance is an established method of screening those 
women without symptoms of preterm labour (asymptomatic) but deemed high-risk 
and aims to identify those who might benefit from a cervical cerclage [7].  However 
cervical insufficiency is likely to represent only one factor in the aetiology of preterm 
birth as more than 50% of those with a short cervix deliver beyond 35 weeks [8].  
 
A range of biochemical bedside tests are available to help distinguish those at most 
risk of preterm labour [9].  Fetal fibronectin (fFN) is the most widely used in the UK 
[10]. In asymptomatic high risk women, it has a negative predictive value for  
spontaneous preterm birth before 30 weeks of 98.6% and a positive predictive value 
of 13.6% (using the conventional fFN threshold of 50ng/mL). [11]  When combined 
with cervical length and clinical history, fFN prediction is enhanced further [12, 13] 
 
The Preterm Surveillance Clinic (PSC) at St Thomas’ Hospital, London, UK, 
combines clinical history, ultrasonic cervical length measurements and fFN to screen 
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women with risk factors for preterm birth. Those triaged as low-risk are managed as 
outpatients (unless they present clinically with symptoms) whilst those thought at 
highest risk of preterm birth, based on screening tests are admitted into hospital for 
observation and prophylactic interventions.  The purpose of this study was to identify 
whether the PSC accurately risk-stratifies asymptomatic high-risk women, by 
comparing neonatal outcomes of those not routinely admitted, compared to those 
admitted into hospital from the PSC on the basis of asymptomatic testing.  
 
 
 
 
Methods 
 
This was a sub-analysis of a large observational study (Evaluation of Fetal 
Fibronectin with a Quantitative Instrument for the Prediction of Preterm birth) 
conducted at St Thomas’ Hospital (London, United Kingdom). Written informed 
consent was obtained from all participants. Women with singleton pregnancies, not 
symptomatic but at risk of preterm birth between 23+0 and 28+0 gestational age 
attending the PSC from 1 October 2010 to 30 June 2015 were selected for this sub-
analysis. The women also had to meet at least one of the inclusion criteria: history of 
previous late miscarriage (16 to 23+6 weeks), previous preterm birth (<37 weeks), 
previous preterm premature rupture of membranes (PPROM) (<37 weeks,) previous 
cervical surgery (eg LLETZ, cone biopsy), uterine abnormalities, and/or cervical 
length <25mm by transvaginal ultrasound). Results from women with vaginal 
bleeding, PPROM, multiple pregnancy, cervical dilation of 3 cm or greater, were 
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excluded from the analysis. Gestational ages were confirmed with standard early 
ultrasound scans.  
 
Both fFN and cervical length measurements were used in conjunction with clinical 
history to risk assess, using methodology defined elsewhere [11] Women at low-risk 
following these assessments were discharged from the clinic between 22 and 24 
weeks. Women deemed high-risk were admitted and managed according to local 
protocols as described in Figure 2. 
 
The data were retrieved from October 2010 to June 2015. The search yielded a group 
of 1253 women eligible for analysis.  The exclusions flow diagram is shown in Figure 
1. We excluded 123 women, as there were inadequate outcome data available. Thus, 
the total number of women who underwent analysis was 1130.  From this group, we 
then identified 66 women who had been admitted to hospital at least once on any of 
their visits (when asymptomatic) between the eligible gestational period as a result of 
their screening test results (poor obstetric history, fFN positive and CL <15mm). The 
clinic policy was to admit only if the fFN was >50ng/mL and the cervical length was 
<15mm, but ultimately this was at the discretion of the senior obstetrician in clinic.  
The remaining 1064 women were managed as outpatients by PSC, the outcomes of 
which were compared to those who were admitted, regardless of whether they were 
subsequently admitted for clinical reasons.   
 
The main outcomes identified and compared between the two groups were gestational 
age at delivery, stillbirth, neonatal admission to SCBU or NICU, neonatal death, 
birthweight, respiratory distress syndrome, intraventricular haemorrhage and Apgar 
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score at 5 minutes. Stillbirth was defined as the death of a baby before or during birth 
after 24 weeks of gestation. Neonatal death was defined as any deaths occurring 
within the first 28 days of life.  
 
 
 
 
Statistical methods 
 
Data were analysed descriptively and inferentially using Graphpad PRISM 6.0 
statistics software. Proportions are presented with 95% exact binomial confidence 
intervals (CI).   
 
The primary outcomes were mean gestational age and a delivery gestation <30 weeks. 
Gestational age at delivery was analysed as a continuous variable and gestational age 
at delivery  <30 weeks was analysed as a nominal variable.   
 
Secondary outcomes were delivery <34 weeks and <37 weeks and mean birthweight.  
All categorical (nominal) variables were compared using chi-square with the 
statistical significance set at p <0.001 to account for the multiple hypothesis testing. 
Student T test was used to calculate the average maternal ages, average weeks of 
gestation at delivery and average birthweights. 
 
 
Results 
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The characteristics of the outpatient and inpatient groups are summarised in Table 1. 
The previous cervical surgery rate, previous preterm birth rate and previous PPROM 
rate were higher in outpatient group. The rate of previous second trimester 
miscarriage was higher in the inpatient group. 
 
Table 2 summarises the outcomes for the outpatient and inpatient groups. Those 
patients admitted when asymptomatic from the PSC were significantly more likely to 
deliver before 30 weeks (RR 27.6) than those patients who were not admitted from 
PSC.  Those discharged had low rates of preterm birth before 30weeks (1.32%), in 
spite of their risk factors and comparable to background risk in England and Wales 
(1.2% <31/40) [1].  The mean gestation at delivery for those managed as outpatients 
was 38.4±2.5 weeks compared to 31.9±5.6 weeks for those admitted from PSC 
(p<0.0001). 
 
The secondary outcomes of rates of delivery gestation <34 weeks and <37 weeks, 
neonatal deaths, stillbirths, APGAR <7, intraventricular haemorrhage, and 
NICU/SCBU admissions were all significantly lower amongst those women managed 
as outpatients by PSC. The mean birthweights of neonates born to women admitted 
from PSC were significantly lower (1.98kg±2.93 vs 3.21kg±0.64, p<0.0001) 
 
In the outpatient group, one of the four stillbirths had an emergency LSCS at 24 
weeks. The remaining 3 stillbirths were not linked to preterm labour –one was an 
intrapartum term stillbirth and two were associated with major congenital 
abnormalities (see table 2).   There was one preterm neonatal death in the outpatient 
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group, in which a woman with severe pre-eclampsia suffered a placental abruption 
and the baby died one hour after birth. The other neonatal death in the outpatient 
group was at 39 weeks and the infant had major cardiac abnormalities. 
 
In the inpatient group all of the stillbirths were associated with extreme prematurity 
(<25 weeks), spontaneous onset of labour and chorioamnionitis.  There were three 
neonatal deaths in the inpatient cohort, all of which were contributed to by extreme 
prematurity.  One infant delivered at 24 weeks and died 2 days after birth, one 
delivered at 23+6 but also had multiple congenital abnormalities, and the last 
delivered at 25+5 weeks and was complicated by sepsis and multiple pulmonary 
haemorrhages.   
 
 
Discussion  
 
Whilst there is existing evidence that combined ultrasonic cervical length screening 
and fFN assists in prediction of preterm birth in asymptomatic women [13, 14], to our 
knowledge, this is the first study into whether a PSC is appropriately triaging high-
risk women. The low incidence of preterm birth and the lack of neonatal 
complications in those patients not admitted from PSC, suggests appropriate selection 
of those not requiring admission or further interventions and justifies the policy of 
discharging from clinic at or before 24 weeks gestation.  
 
The similar prevalence of previous preterm labour or PPROM as risk factors in our 
inpatient and outpatient groups (Table 1) supports the evidence that these risk factors 
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alone are not good screening tools [2]. The higher incidence of previous second 
trimester miscarriage in the inpatient group suggests that these women are more likely 
to have abnormal tests and worse outcomes. 
 
Detailed analysis of the outpatient perinatal mortality emphasises the ability of the 
PSC to identify those not at risk of poor outcomes associated with preterm birth. The 
low stillbirth rate of 0.4%, only includes one case in which prematurity was a 
contributing factor  (the remaining two had major congenital abnormalities). Similarly, 
one of the neonatal deaths was at term, and the other, whilst preterm, was associated 
with pre-eclampsia and placental abruption.   
 
The study’s major strength is the prospectively collected detailed data in a large group 
of high risk women, demonstrating the clinic can accurately risk stratify. This 
provides high levels of reassurance to those not admitted and/or discharged based on 
asymptomatic testing. 
 
The interpretation of the results in the high-risk women is limited by the need to 
establish whether admission itself or the subsequent targeting of interventions is 
improving outcomes.  Given the high morbidity and mortality in this group, and that 
beneficial interventions such as steroid administration and in-utero transfer are time-
sensitive, admission for those at high risk of spontaneous preterm labour as 
determined by PSC is probably justified in the meantime. 
 
We have previously shown that the ultrasonic cervical length screening and fFN act 
synergistically and improve risk prediction when used together . Our study supports 
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their combined use in asymptomatic women to select those at high-risk women for 
admission to hospital. Although these tests and admissions have a cost, the severity of 
outcomes, and the ability to target time sensitive interventions known to improve 
outcomes is likely to justify this practice. Amongst the 1130 high risk women in this 
study, only 66 (5.8%) were electively admitted. With more than one third of those 
admitted delivering before 30 weeks and 73% before 37 weeks, interventions such as 
steroid administration are better justified than women who are given steroids for 
threatened preterm labour alone, where 60% of pregnancies continue beyond 37 
weeks [6].  This suggests that surveillance and targeting of interventions in 
asymptomatic women is justified. 
 
The low rate of false-negative tests might support adjustments to our screening 
thresholds for admission (FFN>50 ng/ml and CL<15mm).  Recent developments in 
quantitative fetal fibronectin levels in high risk asymptomatic women, suggest that 
increasing the fFN threshold from 50 ng/ml to 200 ng/mL doubles the positive 
predictive value to 26.9 (95% confidence interval 17.5-38.2) with only a 0.4% 
reduction in negative predictive value (98.6 to 98.2%), i.e. women under 200 ng/ml 
may be safely discharged. Quantitative fFN also helps discriminate those at low risk 
with a known short cervix (less than 25mm), with 90% of women delivering after 34 
weeks gestation if the fFN is less than 10 ng/m [11].  Combining quantitative fFN 
with risk factors, cervical length provides exciting opportunities for tailoring 
prediction to the individual (12). 
 
This large study with prospectively collected data demonstrates that a preterm 
surveillance clinic admitting asymptomatic women at high-risk of preterm birth, on 
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the basis of cervical length and fFN, correctly identifies those women most at risk of 
poor neonatal outcomes. The particularly low rates of perinatal morbidity and 
mortality in the “outpatient” group provide a high level of reassurance to women with 
negative screens, in spite of their risk factors, and are likely to reduce unnecessary 
admissions and interventions.  
 
As our understanding of the relationship between quantitative fetal fibronectin, 
cervical length and risk factors for prematurity becomes more sophisticated, 
technologies such as the QUIPP App [12] will support preterm surveillance clinics to 
refine risk stratification further.  
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Table 1: Baseline Characteristics 
 
 
 
Outpatients 
N=1064 
Inpatients 
N=66 
Average maternal age (years) 32.8±5.6 (16-48) 32.6±5.1 (21-49)      p = 0.265 
 
Previous preterm birth (%) 36.7 (n=390) 33.3 (n=22)              p=0.55 
Previous PPROM (%) 19.5 (n=208) 15.2 (n=10)              p=0.36 
Previous second trimester 
miscarriage (%) 
19.8 (n=211) 37.9 (n=25)              p=0.0006 
Previous cervical surgery (%) 37.4 (n=398) 18.2 (n=12)              p=0.0014 
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Table 2: Outcomes for patients admitted from PSC vs those managed as outpatients 
 
 Outpatient   Inpatient       RR (95% CI) p value 
 (n=1064) (n=66) 
 
  
Primary outcomes 
 
    
Mean gestation at 
delivery (weeks) 
38.4±2.5 (24-42) 31.2±5.6 (23-41)  p<0.0001 
Delivery less than 
<30/40 
 
 
 
1.32% (n=14)  
 
36.4% (n=24) 27.6 (15.0-50.1) 
 
 
p<0.0001 
Secondary outcomes 
 
 
 
   
 
Delivery <34/40 
 
4.89% (n=52) 
 
57.6% (n=38) 11.8 (8.4-16.5) 
 
p<0.0001 
Delivery <37/40 14.0% (n=149) 72.7% (n=48) 5.2 (4.2-6.4) p<0.0001 
 
 
Stillbirth rate 
 
 
0.376% (n=4) 
 
4.55% (n=3) 12.1 (2.8-52.9) 
 
p<0.0001 
 
Neonatal deaths 
 
 
0.188% (n=2) 
 
4.55% (n=3) 24.2 (4.1-142.2) 
 
p<0.0001 
Intraventricular 
Haemorrhage 
 
0.188% (n=2) 9.09% (n=6) 
48.4 (10.0-235.0) 
  p<0.0001 
Respiratory distress 
syndrome 
 
 
10.2% (n=108) 
 
56.1% (n=37) 5.5 (4.2-7.3) 
 
p<0.0001 
Birthweight 
Mean (kg) 
 
 
<1kg (ELBW) 
<1.5kg (VLBW) 
<2kg 
<2.5kg (LBW) 
 
 
3.21±0.64 (0.680-
5.180) 
 
1.98±2.93      
(0.5000-4.562) 
  
p<0.0001 
0.846% (n=9) 27.3% (n=18) 
32.2 (15.1-69.0) 
p<0.0001 
1.79% (n=19) 36.4% (n=24) 
20.4 (11.8-35.2) 
p<0.0001 
4.70% (n=50) 53.0% (n=35) 
11.3 (7.9-16.1) 
p<0.0001 
11.4% (n=121) 65.2% (n=43) 
5.7 (4.5-7.3) 
p<0.0001 
 
SCBU/NICU 
admission 
 
 
10.2% (n=108)         56.1% (n=37)           5.5 (4.2-7.3)              p<0.0001 
 
APGARS <7 
 
1.50% (n=16)            12.1% (n=8)            8.1 (3.6-18.1)            p<0.0001 
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